Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
Cancer Research|February 1, 2018
Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody-Drug ConjugatesHui Zhao, John Atkinson, Sara Gulesserian, et al.
Molecular Cancer Therapeutics|August 21, 2025
Preclinical characterization of XB010: a novel antibody-drug conjugate for the treatment of solid tumors that targets tumor-associated antigen 5T4Brian A Mendelsohn, Kathleen R Gogas, Jeffrey N Higaki, et al.
NPJ Genomic Medicine|September 24, 2021
Application of full-genome analysis to diagnose rare monogenic disordersJoseph T Shieh, Monica Penon-Portmann, Karen H Y Wong, et al.
Human Molecular Genetics|October 17, 2017
De novo, deleterious sequence variants that alter the transcriptional activity of the homeoprotein PBX1 are associated with intellectual disability and pleiotropic developmental defectsAnne Slavotinek, Maurizio Risolino, Marta Losa, et al.
Clinical Genetics|December 3, 2014
Exome sequencing in 32 patients with anophthalmia/microphthalmia and developmental eye defectsA M Slavotinek, S T Garcia, G Chandratillake, et al.
American Journal of Medical Genetics. Part A|October 24, 2023
Neurodevelopmental and other phenotypes recurrently associated with heterozygous BAZ2B loss-of-function variantsSoha Sewani, Mahshid S Azamian, Bryce A Mendelsohn, et al.
BMC Medicine|August 18, 2021
Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort studyEden V Haverfield, Edward D Esplin, Sienna J Aguilar, et al.
Annals of Clinical and Translational Neurology|December 10, 2019
RARS1-related hypomyelinating leukodystrophy: Expanding the spectrumMarisa I Mendes, Lydia M C Green, Enrico Bertini, et al.
Journal of Inherited Metabolic Disease|September 12, 2022
A multinational study of acute and long-term outcomes of Type 1 galactosemia patients who carry the S135L (c.404C > T) variant of GALTQuinton S Katler, Karolina M Stepien, Nathan Paull, et al.
Science Advances|February 4, 2020
Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancerKezhi Yan, Justine Rousseau, Keren Machol, et al.
Pageof 31